BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38527848)

  • 1. Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database.
    Huo M; Zhang J; Hou M; Li J; Bai N; Xu R; Guo J
    Cancer Invest; 2024 Mar; 42(3):212-225. PubMed ID: 38527848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis.
    Wang D; Yang Y; He Y; Yang H; Yang L
    Cancer Control; 2024; 31():10732748241253956. PubMed ID: 38756002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Nomogram for Predicting Survival in Patients with Thyroid Cancer.
    Wen Q; Yu Y; Yang J; Wang X; Wen J; Wen Y; Wang Y; Lyu J
    Med Sci Monit; 2019 Jul; 25():5561-5571. PubMed ID: 31350384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
    Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
    Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
    Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
    Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
    Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
    Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
    BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
    Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
    Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of a prognostic nomogram for anal squamous cell carcinoma.
    Yang N; Xu L; Wang Q; Chen F; Zhou Y
    Cancer Med; 2022 Jan; 11(2):392-405. PubMed ID: 34850581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
    Wu J; Xie Z; Xiao Y; Wang B; Zhang P
    Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
    Hou G; Zheng Y; Wei D; Li X; Wang F; Tian J; Zhang G; Yan F; Zhu Z; Meng P; Yuan J; Gao M; Li Z; Zhang B; Xing Z; Yuan J
    Medicine (Baltimore); 2019 Sep; 98(39):e17197. PubMed ID: 31574827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.